BamSEC and AlphaSense Join Forces
Learn More

Windtree Therapeutics Inc.

NASDAQ: WINT    
Share price (8/8/25): $0.55    
Market cap (8/8/25): $2.003 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 8 pages Convertible Promissory Note
12/34/56
EX-4.3
from 8-K 17 pages Senior Unsecured Convertible Promissory Note
12/34/56
EX-4.1
from 8-K 17 pages Senior Unsecured Convertible Promissory Note
12/34/56
EX-4.1
from 8-K 17 pages Senior Unsecured Convertible Promissory Note
12/34/56
EX-4.5
from 8-K 13 pages Standard Waste Services, LLC Senior Note
12/34/56
EX-4.3
from 8-K 17 pages Common Stock Purchase Warrant Windtree Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 17 pages Senior Unsecured Convertible Promissory Note
12/34/56
EX-4.1
from 8-K 17 pages Senior Unsecured Convertible Promissory Note
12/34/56
EX-4.30
from 10-K 3 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 19 pages Windtree Therapeutics, Inc. 20% Oid Senior Secured Convertible Promissory Note
12/34/56
EX-4.1
from 8-K 36 pages Windtree Therapeutics, Inc. Senior Secured Note
12/34/56
EX-4.1
from 8-K 3 pages Windtree Therapeutics, Inc. Conversion Notice
12/34/56
EX-4.1
from 8-K 32 pages Windtree Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 34 pages Windtree Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 36 pages Windtree Therapeutics, Inc. Senior Secured Note
12/34/56
EX-4.1
from 8-K 29 pages Windtree Therapeutics, Inc. Senior Unsecured Promissory Note
12/34/56
EX-4.2
from 8-K 35 pages Windtree Therapeutics, Inc. Senior Secured Note
12/34/56
EX-4.1
from 8-K 8 pages Convertible Promissory Note
12/34/56
EX-4.18
from 10-K 2 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 52 pages Windtree Therapeutics, Inc. Senior Convertible Note
12/34/56